OptiBiotix Health PLC Investor evening
September 06 2017 - 3:30AM
RNS Non-Regulatory
TIDMOPTI
OptiBiotix Health PLC
06 September 2017
OptiBiotix Health plc
("OptiBiotix" or "the Company")
Investor evening
OptiBiotix Health plc (AIM: OPTI), a life sciences business
developing products to tackle obesity, high cholesterol and
diabetes, announces that Stephen O'Hara, CEO of Optibiotix, will be
presenting at an investor evening hosted by Turner Pope Investments
Ltd ("TPI"). The event will be held on Tuesday 19 September 2017 in
Mayfair, London and will commence at 5pm.
To register your interest and obtain further details, please
contact TPI on info@turnerpope.com or call 020 3621 4121.
No new material or trading information will be provided.
OptiBiotix Health plc www.optibiotix.com
Stephen O'Hara, Chief Contact via Walbrook below
Executive
Walbrook PR Tel: 020 7933 8780 or optibiotix@walbrookpr.com
Ltd
Anna Dunphy Mob: 07876 741 001
About OptiBiotix Health PLC - www.optibiotix.com
OptiBiotix was formed in March 2012 to develop compounds which
modify the human microbiome - the collective genome of the microbes
in the body - to prevent and manage human disease.
The aim of OptiBiotix is to discover and develop microbial
strains, compounds and formulations, which modulate the human
microbiome and can be used as food ingredients and supplements or
active compounds for the prevention and management of human
diseases, examples of which include obesity, cholesterol and lipid
distribution, diabetes, and skin health.
OptiBiotix has established a pipeline of microbiome modulators
that can impact on lipid and cholesterol management, energy
harvest, appetite suppression, and skin health. The development
pipeline is fuelled by its proprietary OptiScreen(R) and
OptiBiotic(R) platform technologies designed to identify metabolic
pathways and compounds that impact on human physiology and bring
potential health benefits. These platforms are applicable across a
wider range of other human diseases.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRASSUSAMFWSESU
(END) Dow Jones Newswires
September 06, 2017 04:30 ET (08:30 GMT)
Optibiotix Health (LSE:OPTI)
Historical Stock Chart
From Apr 2024 to May 2024
Optibiotix Health (LSE:OPTI)
Historical Stock Chart
From May 2023 to May 2024